Breaking News Instant updates and real-time market news.

ONCS

OncoSec

$1.85 /

-0.05 (-2.63%)

16:28
10/14/21
10/14
16:28
10/14/21
16:28

OncoSec assumed with a Buy at BTIG

BTIG analyst Kaveri Pohlman assumed coverage of OncoSec with a Buy rating and $10 price target. The analyst assumed coverage of 12 Immuno-oncology companies. Pohlman believes "much of the most promising work" involves broader immune involvement in the anti-tumor battle either involving or in combination with less-systemically toxic therapeutic cytokines. The world of allogeneic cellular therapies is "very close to catching the autologous world but that these approaches will always be complex for smaller hospitals to employ leaving this approach for a subset of patients," Pohlman tells investors in a research note.

  • 21

    Jan

OTHER BREAKING NEWS FROM THE FLY

Upgrade
Sinotruk upgraded to Buy from Hold at HSBC » 06:38
12/06/22
12/06
06:38
12/06/22
06:38
SHKLY

Sinotruk

$67.10 /

+ (+0.00%)

HSBC analyst Helen Fang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHKLY Sinotruk
$67.10 /

+ (+0.00%)

04/04/22 JPMorgan
Sinotruk downgraded to Underweight from Neutral at JPMorgan
02/27/22 Goldman Sachs
Sinotruk upgraded to Buy from Neutral at Goldman Sachs
Initiation
Carnival assumed with a Neutral at JPMorgan » 06:38
12/06/22
12/06
06:38
12/06/22
06:38
CCL

Carnival

$9.67 /

-0.33 (-3.30%)

JPMorgan analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$9.67 /

-0.33 (-3.30%)

CCL Carnival
$9.67 /

-0.33 (-3.30%)

11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Carnival price target raised to $16 from $8 at UBS
10/27/22 Tigress Financial
Tigress Financial sees 45% 12-month upside in Carnival shares
10/12/22 UBS
Carnival price target lowered to $8 from $11 at UBS
CCL Carnival
$9.67 /

-0.33 (-3.30%)

  • 21
    Jul
CCL Carnival
$9.67 /

-0.33 (-3.30%)

CCL Carnival
$9.67 /

-0.33 (-3.30%)

CCL Carnival
$9.67 /

-0.33 (-3.30%)

Hot Stocks
Sage Therapeutics, Biogen complete NDA to FDA for zuranolone » 06:37
12/06/22
12/06
06:37
12/06/22
06:37
SAGE

Sage Therapeutics

$43.54 /

-0.05 (-0.11%)

, BIIB

Biogen

$292.64 /

-6.35 (-2.12%)

Sage Therapeutics (SAGE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

BIIB Biogen
$292.64 /

-6.35 (-2.12%)

SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

11/09/22 H.C. Wainwright
Sage Therapeutics price target lowered to $50 from $55 at H.C. Wainwright
11/01/22 Loop Capital
Sage Therapeutics initiated with a Hold at Loop Capital
08/03/22 Citi
Sage Therapeutics price target lowered to $40 from $41 at Citi
08/02/22 Stifel
Sage Therapeutics price target lowered to $56 from $58 at Stifel
BIIB Biogen
$292.64 /

-6.35 (-2.12%)

12/02/22 JonesTrading
Anavex price target raised to $80 from $40 at JonesTrading
12/01/22 Atlantic Equities
Biogen price target raised to $295 from $220 at Atlantic Equities
11/30/22 Mizuho
Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
11/30/22 Jefferies
Biogen price target raised to $350 from $325 at Jefferies
SAGE Sage Therapeutics
$43.54 /

-0.05 (-0.11%)

BIIB Biogen
$292.64 /

-6.35 (-2.12%)

BIIB Biogen
$292.64 /

-6.35 (-2.12%)

BIIB Biogen
$292.64 /

-6.35 (-2.12%)

BIIB Biogen
$292.64 /

-6.35 (-2.12%)

Hot Stocks
Whitestone REIT provides update on disposition activities » 06:37
12/06/22
12/06
06:37
12/06/22
06:37
WSR

Whitestone REIT

$9.57 /

-0.245 (-2.50%)

Whitestone REIT has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSR Whitestone REIT
$9.57 /

-0.245 (-2.50%)

WSR Whitestone REIT
$9.57 /

-0.245 (-2.50%)

12/05/22 Truist
Whitestone REIT price target raised to $10 from $9 at Truist
12/02/22 Truist
Whitestone REIT price target raised to $10 from $9 at Truist
08/30/22 Truist
Truist starts Whitestone REIT at Hold, sees challenging 2023 setup
08/30/22 Truist
Whitestone REIT initiated with a Hold at Truist
Hot Stocks
Editas Medicine's EDIT-301 shows safety and efficacy in sickle cell disease » 06:36
12/06/22
12/06
06:36
12/06/22
06:36
EDIT

Editas Medicine

$9.83 /

-0.425 (-4.15%)

Editas Medicine announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

12/05/22 Credit Suisse
Editas Medicine assumed with a Neutral at Credit Suisse
11/18/22 Morgan Stanley
Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
11/18/22 BofA
Editas' EDIT-101 setback 'not the end of the story,' says BofA
11/18/22 RBC Capital
Editas Medicine price target lowered to $14 from $32 at RBC Capital
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

Hot Stocks
X-energy to go public via merger with Ares Acquisition » 06:36
12/06/22
12/06
06:36
12/06/22
06:36
AAC

Ares Acquisition

$10.04 /

-0.005 (-0.05%)

X Energy Reactor Company,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Royal Caribbean assumed with Underweight from Overweight at JPMorgan » 06:35
12/06/22
12/06
06:35
12/06/22
06:35
RCL

Royal Caribbean

$59.44 /

-1.07 (-1.77%)

, NCLH

Norwegian Cruise Line

$16.22 /

-0.325 (-1.96%)

JPMorgan analyst Daniel…

JPMorgan analyst Daniel Adam double downgraded Royal Caribbean (RCL) to Underweight from Overweight with a price target of $47, down from $106, after assuming coverage of the name. Despite roughly $10B of capital raises so far this year and free cash flow generation that should cover most, but not all, of its future commitments, Royal could face a $400M funding shortfall by the end of next year, Adam tells investors in a research note. Additionally, in order to achieve its investment grade credit rating target by 2025, Royal likely needs to raise an additional $3.5B, via either equity or asset sales, says the analyst. He says that at current levels, a $3.5B equity deal would be 20% dilutive to shareholders. Adam prefers Norwegian Cruise Line (NCLH) to Royal Caribbean, as he sees near-term funding requirements for the former as "less onerous."

ShowHide Related Items >><<
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

11/22/22 Truist
Royal Caribbean price target raised to $62 from $58 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Royal Caribbean price target raised to $76 from $56 at UBS
10/21/22 Tigress Financial
Royal Caribbean shares have upside to $80, says Tigress Financial
NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

11/22/22 Truist
Norwegian Cruise Line price target raised to $21 from $19 at Truist
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Norwegian Cruise Line price target raised to $24 from $15 at UBS
11/11/22 Deutsche Bank
Norwegian Cruise Line price target lowered to $14 from $16 at Deutsche Bank
RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

RCL Royal Caribbean
$59.44 /

-1.07 (-1.77%)

NCLH Norwegian Cruise Line
$16.22 /

-0.325 (-1.96%)

Earnings
KVH Industries reports Q3 non-GAAP EPS 7c, consensus 1c » 06:33
12/06/22
12/06
06:33
12/06/22
06:33
KVHI

KVH Industries

$10.61 /

-0.69 (-6.11%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KVHI KVH Industries
$10.61 /

-0.69 (-6.11%)

KVHI KVH Industries
$10.61 /

-0.69 (-6.11%)

Hot Stocks
Karuna Therapeutics names Bill Meury as CEO, succeeding Steve Paul, M.D. » 06:32
12/06/22
12/06
06:32
12/06/22
06:32
KRTX

Karuna Therapeutics

$227.06 /

-9.145 (-3.87%)

Karuna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

11/01/22 Loop Capital
Karuna Therapeutics initiated with a Buy at Loop Capital
09/29/22 RBC Capital
Karuna Therapeutics price target raised to $293 from $292 at RBC Capital
09/26/22 Wells Fargo
Cerevel Therapeutics initiated with an Overweight at Wells Fargo
09/13/22 Stifel
Karuna Therapeutics price target raised to $295 from $260 at Stifel
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

  • 10
    Aug
KRTX Karuna Therapeutics
$227.06 /

-9.145 (-3.87%)

Periodicals
NLRB says Apple violated law with anti-union tactics, Bloomberg reports » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
AAPL

Apple

$146.61 /

-1.21 (-0.82%)

The Atlanta regional…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$146.61 /

-1.21 (-0.82%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
AAPL Apple
$146.61 /

-1.21 (-0.82%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

Downgrade
Salisbury Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
SAL

Salisbury Bancorp

$31.23 /

+0.14 (+0.45%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

Hot Stocks
F-star Therapeutics presents clinical data on antitumor activity of FS222 » 06:29
12/06/22
12/06
06:29
12/06/22
06:29
FSTX

F-star Therapeutics

$5.56 /

-0.03 (-0.54%)

F-star Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

07/15/22 H.C. Wainwright
F-star Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/23/22 SVB Leerink
F-star Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/23/22 Laidlaw
F-star Therapeutics downgraded to Hold from Buy at Laidlaw
06/23/22 Ladenburg
F-star Therapeutics downgraded to Neutral from Buy at Ladenburg
FSTX F-star Therapeutics
$5.56 /

-0.03 (-0.54%)

Recommendations
DocuSign price target lowered to $59 from $76 at Citi » 06:26
12/06/22
12/06
06:26
12/06/22
06:26
DOCU

DocuSign

$42.44 /

-4.135 (-8.88%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
12/05/22 Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
10/12/22 Wedbush
Wedbush upgrades DocuSign to Neutral with $55 price target
DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

DOCU DocuSign
$42.44 /

-4.135 (-8.88%)

Hot Stocks
Cenovus Energy reports 2023 budget and production guidance » 06:25
12/06/22
12/06
06:25
12/06/22
06:25
CVE

Cenovus Energy

$19.17 /

-0.78 (-3.91%)

Cenovus Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

11/21/22 Credit Suisse
Cenovus Energy price target lowered to C$35 from C$37 at Credit Suisse
11/21/22 Goldman Sachs
Cenovus Energy downgraded to Neutral from Buy at Goldman Sachs
11/03/22 Raymond James
Cenovus Energy price target raised to C$32 from C$30 at Raymond James
11/03/22 RBC Capital
Cenovus Energy price target raised to C$32 from C$31 at RBC Capital
CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

CVE Cenovus Energy
$19.17 /

-0.78 (-3.91%)

Hot Stocks
Standard Lithium signs key agreement for access to commercial lithium plant » 06:24
12/06/22
12/06
06:24
12/06/22
06:24
SLI

Standard Lithium

$3.88 /

-0.295 (-7.07%)

Standard Lithium is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLI Standard Lithium
$3.88 /

-0.295 (-7.07%)

SLI Standard Lithium
$3.88 /

-0.295 (-7.07%)

03/15/22 Stifel
Standard Lithium resumed with a Buy at Stifel
Recommendations
PVH Corp. price target raised to $72 from $60 at Barclays » 06:22
12/06/22
12/06
06:22
12/06/22
06:22
PVH

PVH Corp.

$71.15 /

-1.79 (-2.45%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

12/05/22 Deutsche Bank
PVH Corp. price target raised to $77 from $72 at Deutsche Bank
12/05/22 Citi
PVH Corp. price target raised to $74 from $60 at Citi
12/02/22 UBS
PVH Corp. price target raised to $100 from $84 at UBS
12/02/22 Morgan Stanley
PVH Corp. assumed with an Equal Weight at Morgan Stanley
PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

PVH PVH Corp.
$71.15 /

-1.79 (-2.45%)

Recommendations
G-III Apparel price target lowered to $13 from $18 at Barclays » 06:22
12/06/22
12/06
06:22
12/06/22
06:22
GIII

G-III Apparel

$12.25 /

-0.5 (-3.92%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIII G-III Apparel
$12.25 /

-0.5 (-3.92%)

GIII G-III Apparel
$12.25 /

-0.5 (-3.92%)

12/02/22 KeyBanc
G-III Apparel price target lowered to $17 from $27 at KeyBanc
12/01/22 CL King
G-III Apparel downgraded to Neutral from Buy at CL King
12/01/22 CL King
G-III Apparel downgraded to Neutral from Buy at CL King
12/01/22 Piper Sandler
G-III Apparel downgraded to Neutral from Overweight at Piper Sandler
GIII G-III Apparel
$12.25 /

-0.5 (-3.92%)

GIII G-III Apparel
$12.25 /

-0.5 (-3.92%)

Recommendations
Regency Centers price target raised to $69 from $62 at Barclays » 06:21
12/06/22
12/06
06:21
12/06/22
06:21
REG

Regency Centers

$64.79 /

-0.99 (-1.51%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REG Regency Centers
$64.79 /

-0.99 (-1.51%)

REG Regency Centers
$64.79 /

-0.99 (-1.51%)

11/21/22 Evercore ISI
Regency Centers downgraded to In Line from Outperform at Evercore ISI
10/07/22 Deutsche Bank
Regency Centers price target lowered to $69 from $72 at Deutsche Bank
09/27/22 Evercore ISI
Regency Centers price target lowered to $68 from $72 at Evercore ISI
08/22/22 Truist
Regency Centers price target raised to $75 from $67 at Truist
REG Regency Centers
$64.79 /

-0.99 (-1.51%)

Recommendations
Kite Realty Group price target raised to $27 from $24 at Barclays » 06:21
12/06/22
12/06
06:21
12/06/22
06:21
KRG

Kite Realty Group

/

+

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRG Kite Realty Group
/

+

11/09/22 BofA
Kite Realty Group upgraded to Buy from Neutral at BofA
10/07/22 Piper Sandler
Kite Realty Group price target lowered to $24 from $25 at Piper Sandler
09/19/22 Citi
Kite Realty Group upgraded to Buy from Neutral at Citi
08/15/22 Baird
Kite Realty Group price target raised to $26 from $25 at Baird
KRG Kite Realty Group
/

+

KRG Kite Realty Group
/

+

Recommendations
Kimco Realty price target raised to $26 from $24 at Barclays » 06:20
12/06/22
12/06
06:20
12/06/22
06:20
KIM

Kimco Realty

/

+

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KIM Kimco Realty
/

+

KIM Kimco Realty
/

+

11/21/22 Evercore ISI
Kimco Realty downgraded to In Line from Outperform at Evercore ISI
11/11/22 Mizuho
Kimco Realty price target lowered to $22 from $25 at Mizuho
10/20/22 Truist
Kimco Realty price target lowered to $25 from $27 at Truist
10/13/22 Piper Sandler
Kroger, Albertsons merger could allow Kimco to 'cash out,' says Piper Sandler
KIM Kimco Realty
/

+

Recommendations
Amgen price target raised to $310 from $300 at Oppenheimer » 06:20
12/06/22
12/06
06:20
12/06/22
06:20
AMGN

Amgen

$284.96 /

-0.43 (-0.15%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$284.96 /

-0.43 (-0.15%)

AMGN Amgen
$284.96 /

-0.43 (-0.15%)

12/05/22 Piper Sandler
Amgen price target raised to $297 from $278 at Piper Sandler
12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/17/22 Credit Suisse
Amgen initiated with an Underperform at Credit Suisse
AMGN Amgen
$284.96 /

-0.43 (-0.15%)

AMGN Amgen
$284.96 /

-0.43 (-0.15%)

AMGN Amgen
$284.96 /

-0.43 (-0.15%)

AMGN Amgen
$284.96 /

-0.43 (-0.15%)

Recommendations
Federal Realty price target raised to $129 from $114 at Barclays » 06:20
12/06/22
12/06
06:20
12/06/22
06:20
FRT

Federal Realty

$107.00 /

-2.42 (-2.21%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRT Federal Realty
$107.00 /

-2.42 (-2.21%)

FRT Federal Realty
$107.00 /

-2.42 (-2.21%)

11/11/22 Mizuho
Federal Realty price target lowered to $109 from $125 at Mizuho
10/07/22 Piper Sandler
Federal Realty price target lowered to $115 from $125 at Piper Sandler
09/27/22 Evercore ISI
Federal Realty price target lowered to $110 from $119 at Evercore ISI
08/22/22 Truist
Federal Realty price target lowered to $120 from $125 at Truist
FRT Federal Realty
$107.00 /

-2.42 (-2.21%)

FRT Federal Realty
$107.00 /

-2.42 (-2.21%)

Recommendations
Brixmor price target raised to $28 from $26 at Barclays » 06:20
12/06/22
12/06
06:20
12/06/22
06:20
BRX

Brixmor

$22.58 /

-0.455 (-1.98%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRX Brixmor
$22.58 /

-0.455 (-1.98%)

BRX Brixmor
$22.58 /

-0.455 (-1.98%)

11/11/22 Mizuho
Brixmor price target lowered to $22 from $26 at Mizuho
10/27/22 Barclays
Brixmor price target lowered to $26 from $29 at Barclays
10/07/22 Deutsche Bank
Brixmor price target lowered to $21 from $23 at Deutsche Bank
10/07/22 Piper Sandler
Brixmor price target lowered to $25 from $26 at Piper Sandler
BRX Brixmor
$22.58 /

-0.455 (-1.98%)

BRX Brixmor
$22.58 /

-0.455 (-1.98%)

Hot Stocks
NanoString begins shipment of CosMx SMI, AtoMx SIP » 06:19
12/06/22
12/06
06:19
12/06/22
06:19
NSTG

NanoString

$7.08 /

-0.185 (-2.55%)

NanoString Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSTG NanoString
$7.08 /

-0.185 (-2.55%)

NSTG NanoString
$7.08 /

-0.185 (-2.55%)

11/10/22 Canaccord
NanoString price target lowered to $14 from $30 at Canaccord
11/08/22 Cowen
NanoString price target lowered to $24 from $31 at Cowen
11/08/22 Baird
NanoString price target lowered to $14 from $21 at Baird
08/05/22 Baird
NanoString price target lowered to $21 from $30 at Baird
NSTG NanoString
$7.08 /

-0.185 (-2.55%)

NSTG NanoString
$7.08 /

-0.185 (-2.55%)

NSTG NanoString
$7.08 /

-0.185 (-2.55%)

Hot Stocks
Achilles Therapeutics' cNeT shows "encouraging" response in two cancer trials » 06:19
12/06/22
12/06
06:19
12/06/22
06:19
ACHL

Achilles Therapeutics

$1.71 /

-0.035 (-2.01%)

Achilles Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$1.71 /

-0.035 (-2.01%)

ACHL Achilles Therapeutics
$1.71 /

-0.035 (-2.01%)

05/27/22 Piper Sandler
Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
05/10/22 Piper Sandler
Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
03/01/22 Piper Sandler
Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
ACHL Achilles Therapeutics
$1.71 /

-0.035 (-2.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.